AVDL Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

SPRZEDAż 109825 min ago

@ $14.22

Wydano: 14 vas. 2024 @ 16:32

Zwrot: 27.71%

Poprzedni sygnał: vas. 13 - 16:30

Poprzedni sygnał: Kupno

Zwrot: -0.21 %

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	723 170
Średni wolumen	1.19M
Kapitalizacja rynkowa	1.84B
EPS	$0 ( 2024-03-04 )
Następna data zysków	( $-0.250 ) 2024-05-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-9.08
ATR14	$0.0240 (0.13%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-20	Kim Richard J	Buy	147 000	Stock Option (Right to Buy)
2024-02-20	Mchugh Thomas S	Buy	157 500	Stock Option (Right to Buy)
2024-02-20	Divis Gregory J	Buy	600 000	Stock Option (Right to Buy)
2024-01-16	Mchugh Thomas S	Buy	2 000	ADSs
2023-12-28	Mccamish Mark Anthony	Sell	75 000	ADSs

INSIDER POWER
81.01
Last 94 transactions
Buy: 6 417 800 \| Sell: 317 647

Wolumen Korelacja

Długi: -0.17 (neutral)

Krótki: 0.08 (neutral)

Signal:(25.243) Neutral

Avadel Pharmaceuticals Korelacja

10 Najbardziej pozytywne korelacje
HSKA	0.968
ATRS	0.958
LIQT	0.946
ISEE	0.944
XLRN	0.94
BLU	0.936
OVID	0.934
CFIV	0.933
MNST	0.93
LABP	0.93

10 Najbardziej negatywne korelacje
PEAR	-0.951
MTEX	-0.946
VYNT	-0.944
NTGR	-0.939
CFBK	-0.937
HMST	-0.931
VORB	-0.93
INFN	-0.929
AUB	-0.927
EVBG	-0.925

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Avadel Pharmaceuticals Korelacja - Waluta/Towar

-0.23
( neutral )

-0.19
( neutral )

0.00
( neutral )

-0.28
( neutral )

-0.37
( neutral )

0.09
( neutral )

Avadel Pharmaceuticals Finanse

Annual	2023
Przychody:	$27.96M
Zysk brutto:	$25.35M (90.66 %)
EPS:	$-2.00

FY	2023
Przychody:	$27.96M
Zysk brutto:	$25.35M (90.66 %)
EPS:	$-2.00

FY	2022
Przychody:	$0
Zysk brutto:	$-1.49M (0.00 %)
EPS:	$-2.29

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-1.320

Financial Reports:

No articles found.

Avadel Pharmaceuticals

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

Aktualne aktualizacje dla Avadel Pharmaceuticals [AVDL]

Upcoming Earnings Alert